In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
April 7th, 2010 | 26 | Yes |
Popular Name: AZD 5438 AZD 5438
Find On: PubMed — Wikipedia — Google
CAS Numbers: 602306-29-6 , [602306-29-6]
4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.63 | 8.32 | -41.84 | 2 | 7 | 1 | 91 | 372.474 | 5 | ↓ |
Mid Mid (pH 6-8) | 1.63 | 7.85 | -19.57 | 1 | 7 | 0 | 90 | 371.466 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | CDK | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 45 | 0.40 | Binding ≤ 10μM |
CCNB1-1-E | G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 16 | 0.42 | Binding ≤ 10μM |
CCND3-1-E | G1/S-specific Cyclin D3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 21 | 0.41 | Binding ≤ 10μM |
CCNE1-1-E | G1/S-specific Cyclin E1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6 | 0.44 | Binding ≤ 10μM |
CCNT1-1-E | Cyclin T1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 20 | 0.41 | Binding ≤ 10μM |
CDK1-1-E | Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 62 | 0.39 | Binding ≤ 10μM |
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 6 | 0.44 | Binding ≤ 10μM |
CDK4-1-E | Cyclin-dependent Kinase 4 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 450 | 0.34 | Binding ≤ 10μM |
KCNH2-2-E | HERG (cluster #2 Of 5), Eukaryotic | Eukaryotes | 3200 | 0.30 | Binding ≤ 10μM |
Z80211-1-O | LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other | Other | 800 | 0.33 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 45 | 0.40 | Binding ≤ 1μM |
CCNT1_HUMAN | O60563 | Cyclin T1, Human | 20 | 0.41 | Binding ≤ 1μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 62 | 0.39 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 6 | 0.44 | Binding ≤ 1μM |
CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 450 | 0.34 | Binding ≤ 1μM |
CCND3_HUMAN | P30281 | G1/S-specific Cyclin D3, Human | 21 | 0.41 | Binding ≤ 1μM |
CCNE1_HUMAN | P24864 | G1/S-specific Cyclin E1, Human | 6 | 0.44 | Binding ≤ 1μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 16 | 0.42 | Binding ≤ 1μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 45 | 0.40 | Binding ≤ 10μM |
CCNT1_HUMAN | O60563 | Cyclin T1, Human | 20 | 0.41 | Binding ≤ 10μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 62 | 0.39 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 6 | 0.44 | Binding ≤ 10μM |
CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 450 | 0.34 | Binding ≤ 10μM |
CCND3_HUMAN | P30281 | G1/S-specific Cyclin D3, Human | 21 | 0.41 | Binding ≤ 10μM |
CCNE1_HUMAN | P24864 | G1/S-specific Cyclin E1, Human | 6 | 0.44 | Binding ≤ 10μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 16 | 0.42 | Binding ≤ 10μM |
KCNH2_HUMAN | Q12809 | HERG, Human | 3200 | 0.30 | Binding ≤ 10μM |
Z80211 | Z80211 | LoVo (Colon Adenocarcinoma Cells) | 630 | 0.33 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
Activation of the pre-replicative complex | |
APC/C:Cdc20 mediated degradation of Cyclin B | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
Condensation of Prometaphase Chromosomes | |
Condensation of Prophase Chromosomes | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin B2 mediated events | |
Cyclin D associated events in G1 | |
Cyclin E associated events during G1/S transition | |
Depolymerisation of the Nuclear Lamina | |
DNA Damage/Telomere Stress Induced Senescence | |
E2F mediated regulation of DNA replication | |
E2F-enabled inhibition of pre-replication complex formation | |
ERK1 activation | |
Factors involved in megakaryocyte development and platelet production | |
Formation of HIV elongation complex in the absence of HIV Tat | |
Formation of HIV-1 elongation complex containing HIV-1 Tat | |
Formation of RNA Pol II elongation complex | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2 Phase | |
G2/M DNA replication checkpoint | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
HIV elongation arrest and recovery | |
Interactions of Tat with host cellular proteins | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MASTL Facilitates Mitotic Progression | |
Meiotic recombination | |
Nuclear Pore Complex (NPC) Disassembly | |
Oncogene Induced Senescence | |
Orc1 removal from chromatin | |
Oxidative Stress Induced Senescence | |
p53-Dependent G1 DNA Damage Response | |
Pausing and recovery of HIV elongation | |
Pausing and recovery of Tat-mediated HIV elongation | |
Phosphorylation of Emi1 | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
Phosphorylation of the APC/C | |
Polo-like kinase mediated events | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of PLK1 Activity at G2/M Transition | |
Resolution of Sister Chromatid Cohesion | |
RMTs methylate histone arginines | |
RNA Polymerase II Pre-transcription Events | |
RNA Polymerase II Transcription Elongation | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
Tat-mediated elongation of the HIV-1 transcript | |
Tat-mediated HIV elongation arrest and recovery | |
Transcriptional regulation of white adipocyte differentiation | |
Ubiquitin-dependent degradation of Cyclin D1 | |
Voltage gated Potassium channels |
No pre-computed analogs available. Try a structural similarity search.